# Olema Pharmaceuticals, Inc.: Form 8-K, filed May 1, 2026

- Company: [Olema Pharmaceuticals, Inc.](/companies/olma.md) (CIK 1750284)
- Form: 8-K
- Filed: 2026-05-01
- Accepted by EDGAR: May 1, 2026, 21:27 ET
- Period: 2026-04-27
- Accession: 0001193125-26-201751
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1750284/000119312526201751/olma-20260427.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1750284/000119312526201751/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1750284/000119312526201751/olma-20260427.htm

Filed May 1, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-201751. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.